- Home
- MDV vs SGMO Comparison
MDV vs SGMO Comparison
Compare MDV & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDV
- SGMO
- Stock Information
- Founded
- MDV 2015
- SGMO 1995
- Country
- MDV United States
- SGMO United States
- Employees
- MDV N/A
- SGMO N/A
- Industry
- MDV Transportation Services
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MDV Consumer Discretionary
- SGMO Health Care
- Exchange
- MDV Nasdaq
- SGMO Nasdaq
- Market Cap
- MDV 147.6M
- SGMO 122.8M
- IPO Year
- MDV 2022
- SGMO 2000
- Fundamental
- Price
- MDV $14.77
- SGMO $0.58
- Analyst Decision
- MDV
- SGMO Buy
- Analyst Count
- MDV 0
- SGMO 6
- Target Price
- MDV N/A
- SGMO $4.50
- AVG Volume (30 Days)
- MDV 43.3K
- SGMO 7.8M
- Earning Date
- MDV 08-07-2025
- SGMO 08-07-2025
- Dividend Yield
- MDV 7.91%
- SGMO N/A
- EPS Growth
- MDV N/A
- SGMO N/A
- EPS
- MDV N/A
- SGMO N/A
- Revenue
- MDV $47,273,000.00
- SGMO $81,706,000.00
- Revenue This Year
- MDV $2.21
- SGMO $1.29
- Revenue Next Year
- MDV $4.45
- SGMO $1.60
- P/E Ratio
- MDV N/A
- SGMO N/A
- Revenue Growth
- MDV N/A
- SGMO 565.52
- 52 Week Low
- MDV $13.62
- SGMO $0.41
- 52 Week High
- MDV $18.11
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- MDV 51.97
- SGMO 58.57
- Support Level
- MDV $14.35
- SGMO $0.50
- Resistance Level
- MDV $15.65
- SGMO $0.58
- Average True Range (ATR)
- MDV 0.39
- SGMO 0.05
- MACD
- MDV 0.04
- SGMO 0.00
- Stochastic Oscillator
- MDV 42.11
- SGMO 84.21
About MDV Modiv Industrial Inc. Class C
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.